A large new study has raised an important question about whether all heart attack survivors really need to stay on beta-blockers for years, especially if they don’t have heart failure. Beta-blockers are common medications used to treat heart conditions.
They work by slowing down the heart rate and reducing the heart’s workload, which can help prevent further heart problems. These drugs are often given to people after a heart attack to lower the chance of having another one. But until now, it wasn’t clear if everyone benefits from taking them for a long time.
The study, published in the medical journal Heart, looked at medical records from over 43,000 people in England who had heart attacks between 2005 and 2016. The researchers focused on people who had not developed heart failure or a specific heart condition called left ventricular systolic dysfunction, or LVSD.
This condition affects the heart’s ability to pump blood and is known to respond well to beta-blockers. The aim was to see if people without these complications still got any benefit from taking beta-blockers more than one year after their heart attack.
The results were surprising. The researchers followed the patients for an average of 4.5 years and found that there was no major difference in survival or in the risk of having another heart problem between those who continued taking beta-blockers and those who didn’t.
In other words, long-term use of these drugs didn’t seem to help people without heart failure live longer or stay healthier.
It’s important to note that this study was observational. This means the researchers looked at existing data rather than assigning treatments to patients in a controlled setting.
Because of this, they can’t say for sure that stopping beta-blockers is completely safe or that the drug has no benefit. There were also some gaps in the data, like how regularly people took their medications or how they were feeling in daily life.
Still, the findings suggest that it might be time to rethink how beta-blockers are used after a heart attack—at least for patients who have recovered well and don’t have ongoing heart damage.
These drugs can cause side effects, such as feeling tired or even depressed. If they aren’t clearly helping certain patients, doctors and patients should consider whether continuing them is the right choice.
In an editorial published with the study, heart specialists said that while beta-blockers are clearly useful in many cases, especially right after a heart attack or in people with heart failure, we need better evidence to understand their role in patients who are doing well and taking other heart medications like statins or blood pressure drugs.
They called for more research, especially large, randomized studies that could provide stronger answers.
For now, if you or someone you know has had a heart attack and is wondering whether long-term beta-blockers are needed, the best step is to talk to a doctor. Each person’s health is different, and medication decisions should be made together with a healthcare provider.
This study is part of a bigger conversation happening in heart health research. Other recent studies have looked at topics like how aspirin might raise the risk of heart failure in some people, or how low levels of vitamin D could increase heart disease risk.
There’s also promising research into how vitamins like K2 might help reduce the risk of heart problems by preventing dangerous plaque buildup in the arteries.
As scientists learn more, the goal remains the same: to help people recover fully after a heart attack and live long, healthy lives—with as few unnecessary medications and side effects as possible.
If you care about health, please read studies about the benefits of low-dose lithium supplements, and what we know about egg intake and heart disease.
For more health information, please see recent studies about potatoes and high blood pressure, and results showing 6 best breads for people with heart disease.
Copyright © 2025 Knowridge Science Report. All rights reserved.
